Biomolecular Life Holdings, Inc. BIOM
OTC PK
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | -1.72% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | -1.72% | ||||
| Operating Income | 1.72% | ||||
| Income Before Tax | -162.18% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -162.18% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -162.18% | ||||
| EBIT | 1.72% | ||||
| EBITDA | -- | ||||
| EPS Basic | 77.92% | ||||
| Normalized Basic EPS | 77.92% | ||||
| EPS Diluted | 77.92% | ||||
| Normalized Diluted EPS | 77.92% | ||||
| Average Basic Shares Outstanding | 1,087.00% | ||||
| Average Diluted Shares Outstanding | 1,087.00% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||